ANTX AN2 Therapeutics, Inc.
Healthcare$4.73-2.47%ClosedMarket Cap: $129.6M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
3
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+8,742
Shares Acquired
8,742
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 10 | Martin Patricia A. | director | Sell | 1,192 | $0.00 | 18,097 |
| Fri Apr 10 | Marks Gilbert Lynn | director | Sell | 3,775 | $0.00 | 79,084 |
| Fri Apr 10 | Aziz Kabeer | director | Sell | 3,775 | $0.00 | 56,254 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 82,300 | $14.29 | 0 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 73,665 | $6.60 | 0 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 66,000 | $17.28 | 0 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 82,300 | $3.91 | 82,300 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 73,665 | $3.91 | 73,665 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 66,000 | $3.91 | 66,000 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 66,000 | $17.28 | 0 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 66,000 | $3.91 | 66,000 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 57,950 | $3.91 | 57,950 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 41,665 | $3.91 | 41,665 |